The long term goal of this research is to understand the transport mechanisms of transdermal absorption such that more reliable and predictable drug delivery systems may be designed. Because of a continued need for safe and effective agents to regulate fertility, the investigation is focussed on the delivery of contraceptive drugs.
The specific aims of the project are: (1) to evaluate the relationship between drug structure and chemical properties and percutaneous absorption in humans; (2) to determine the rate- limiting process in skin penetration as a function of drug structure and properties; (3) to define the level by which transdermal absorption in vivo may be increased using penetration `enhancers'; (4) to comprehend the mechanism(s) by which skin penetration `enhancers' function. Experiments are performed in vivo in man and in vitro using human skin excised during plastic surgery. Penetration measurements in the presence and absence of `enhancers' utilize novel mass balance and surface disappearance techniques following topical application of radiolabeled drug. Local `enhancer' effects under occlusion are monitored by transepidermal water loss and laser Doppler velocimetry. Drug passage across and localization within the skin is measured by reflectance Fourier-transform infrared spectroscopy (FTIR). Status and perturbations (by the `enhancers') to stratum corneum lipid structure are assessed by FTIR and differential scanning calorimetry. To probe, at a molecular level, the significance of stratum corneum lipid composition and organization, an air-liquid keratinocyte culture is established, manipulated and subjected to examination by physical techniques. Model experiments using closed vesicles prepared from stratum corneum lipids are concurrently undertaken to reinforce the studies in culture. Overall, therefore, the project aims to establish mechanisms of transdermal absorption by the judicious application of biophysical, bioengineering and biochemical techniques to the interpretation of drug penetration and its enhancement through human skin in vivo.

Project Start
1987-04-01
Project End
1991-03-31
Budget Start
1988-04-01
Budget End
1989-03-31
Support Year
2
Fiscal Year
1988
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
Schools of Pharmacy
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Kalia, Y N; Nonato, L B; Lund, C H et al. (1998) Development of skin barrier function in premature infants. J Invest Dermatol 111:320-6
Pirot, F; Kalia, Y N; Stinchcomb, A L et al. (1997) Characterization of the permeability barrier of human skin in vivo. Proc Natl Acad Sci U S A 94:1562-7
Kalia, Y N; Pirot, F; Guy, R H (1996) Homogeneous transport in a heterogeneous membrane: water diffusion across human stratum corneum in vivo. Biophys J 71:2692-700
Tsai, J C; Guy, R H; Thornfeldt, C R et al. (1996) Metabolic approaches to enhance transdermal drug delivery. 1. Effect of lipid synthesis inhibitors. J Pharm Sci 85:643-8
Gay, C L; Guy, R H; Golden, G M et al. (1994) Characterization of low-temperature (i.e., < 65 degrees C) lipid transitions in human stratum corneum. J Invest Dermatol 103:233-9
Cullander, C (1994) Imaging in the far-red with electronic light microscopy: requirements and limitations. J Microsc 176:281-6
Higo, N; Naik, A; Bommannan, D B et al. (1993) Validation of reflectance infrared spectroscopy as a quantitative method to measure percutaneous absorption in vivo. Pharm Res 10:1500-6
Bommannan, D; Menon, G K; Okuyama, H et al. (1992) Sonophoresis. II. Examination of the mechanism(s) of ultrasound-enhanced transdermal drug delivery. Pharm Res 9:1043-7
Bommannan, D; Okuyama, H; Stauffer, P et al. (1992) Sonophoresis. I. The use of high-frequency ultrasound to enhance transdermal drug delivery. Pharm Res 9:559-64
Potts, R O; Guy, R H (1992) Predicting skin permeability. Pharm Res 9:663-9

Showing the most recent 10 out of 35 publications